Children with the condition are also more likely to have severe infections, the study suggests.
Estimates didn’t differ substantially between immune-compromised and not–immune-compromised adults.
The FDA had refused to review the original application because it said Moderna’s phase 3 study was not "adequate and well-controlled."
Infectious disease information from CIDRAP.
Discussion & analysis on the latest infectious disease developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and Osterholm Update podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
"Right now, we're seeing on a global basis a retrenchment in vaccine research and development, because the United States is in fact the 800-pound gorilla in the corner that really drives how vaccines are purchased, how they're used."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
